Organon & Co (OGN)
14.45
-0.27
(-1.83%)
USD |
NYSE |
Apr 03, 16:00
14.43
-0.02
(-0.14%)
After-Hours: 20:00
Organon Shareholders Equity (Quarterly): 472.00M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 67.09M |
| Palatin Technologies Inc | -6.381M |
| Vertex Pharmaceuticals Inc | 16.41B |
| Agios Pharmaceuticals Inc | 1.541B |
| Blueprint Medicines Corp | 298.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.10B |
| Total Liabilities (Quarterly) | 12.63B |
| Debt to Equity Ratio | 18.81 |
| Current Ratio | 1.600 |
| Net Debt Paydown Yield | -1.18% |